254 related articles for article (PubMed ID: 27313059)
1. Human sterol 14α-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design.
Hargrove TY; Friggeri L; Wawrzak Z; Sivakumaran S; Yazlovitskaya EM; Hiebert SW; Guengerich FP; Waterman MR; Lepesheva GI
J Lipid Res; 2016 Aug; 57(8):1552-63. PubMed ID: 27313059
[TBL] [Abstract][Full Text] [Related]
2. Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.
Hargrove TY; Wawrzak Z; Alexander PW; Chaplin JH; Keenan M; Charman SA; Perez CJ; Waterman MR; Chatelain E; Lepesheva GI
J Biol Chem; 2013 Nov; 288(44):31602-15. PubMed ID: 24047900
[TBL] [Abstract][Full Text] [Related]
3. Sterol 14α-Demethylase Structure-Based Design of VNI (( R)- N-(1-(2,4-Dichlorophenyl)-2-(1 H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic Analysis.
Friggeri L; Hargrove TY; Wawrzak Z; Blobaum AL; Rachakonda G; Lindsley CW; Villalta F; Nes WD; Botta M; Guengerich FP; Lepesheva GI
J Med Chem; 2018 Jul; 61(13):5679-5691. PubMed ID: 29894182
[TBL] [Abstract][Full Text] [Related]
4. Validation of Human Sterol 14α-Demethylase (CYP51) Druggability: Structure-Guided Design, Synthesis, and Evaluation of Stoichiometric, Functionally Irreversible Inhibitors.
Friggeri L; Hargrove TY; Wawrzak Z; Guengerich FP; Lepesheva GI
J Med Chem; 2019 Nov; 62(22):10391-10401. PubMed ID: 31663733
[TBL] [Abstract][Full Text] [Related]
5. Structural complex of sterol 14α-demethylase (CYP51) with 14α-methylenecyclopropyl-Delta7-24, 25-dihydrolanosterol.
Hargrove TY; Wawrzak Z; Liu J; Waterman MR; Nes WD; Lepesheva GI
J Lipid Res; 2012 Feb; 53(2):311-20. PubMed ID: 22135275
[TBL] [Abstract][Full Text] [Related]
6. Sterol 14α-Demethylase Structure-Based Optimization of Drug Candidates for Human Infections with the Protozoan Trypanosomatidae.
Friggeri L; Hargrove TY; Rachakonda G; Blobaum AL; Fisher P; de Oliveira GM; da Silva CF; Soeiro MNC; Nes WD; Lindsley CW; Villalta F; Guengerich FP; Lepesheva GI
J Med Chem; 2018 Dec; 61(23):10910-10921. PubMed ID: 30451500
[TBL] [Abstract][Full Text] [Related]
7. Structural and Functional Elucidation of Yeast Lanosterol 14α-Demethylase in Complex with Agrochemical Antifungals.
Tyndall JD; Sabherwal M; Sagatova AA; Keniya MV; Negroni J; Wilson RK; Woods MA; Tietjen K; Monk BC
PLoS One; 2016; 11(12):e0167485. PubMed ID: 27907120
[TBL] [Abstract][Full Text] [Related]
8. Structural analyses of
Hargrove TY; Friggeri L; Wawrzak Z; Qi A; Hoekstra WJ; Schotzinger RJ; York JD; Guengerich FP; Lepesheva GI
J Biol Chem; 2017 Apr; 292(16):6728-6743. PubMed ID: 28258218
[TBL] [Abstract][Full Text] [Related]
9. Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
Sagatova AA; Keniya MV; Tyndall JDA; Monk BC
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263059
[TBL] [Abstract][Full Text] [Related]
10. Identification of Potent and Selective Inhibitors of
Hargrove TY; Lamb DC; Wawrzak Z; Hull M; Kelly SL; Guengerich FP; Lepesheva GI
J Med Chem; 2024 May; 67(9):7443-7457. PubMed ID: 38683753
[No Abstract] [Full Text] [Related]
11. VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis.
Lepesheva GI; Hargrove TY; Rachakonda G; Wawrzak Z; Pomel S; Cojean S; Nde PN; Nes WD; Locuson CW; Calcutt MW; Waterman MR; Daniels JS; Loiseau PM; Villalta F
J Infect Dis; 2015 Nov; 212(9):1439-48. PubMed ID: 25883390
[TBL] [Abstract][Full Text] [Related]
12. Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum.
Hargrove TY; Wawrzak Z; Liu J; Nes WD; Waterman MR; Lepesheva GI
J Biol Chem; 2011 Jul; 286(30):26838-48. PubMed ID: 21632531
[TBL] [Abstract][Full Text] [Related]
13. Homology model, molecular dynamics simulation and novel pyrazole analogs design of Candida albicans CYP450 lanosterol 14 α-demethylase, a target enzyme for antifungal therapy.
Jacob K S; Ganguly S; Kumar P; Poddar R; Kumar A
J Biomol Struct Dyn; 2017 May; 35(7):1446-1463. PubMed ID: 27142238
[TBL] [Abstract][Full Text] [Related]
14. Structure-Functional Characterization of Cytochrome P450 Sterol 14α-Demethylase (CYP51B) from Aspergillus fumigatus and Molecular Basis for the Development of Antifungal Drugs.
Hargrove TY; Wawrzak Z; Lamb DC; Guengerich FP; Lepesheva GI
J Biol Chem; 2015 Sep; 290(39):23916-34. PubMed ID: 26269599
[TBL] [Abstract][Full Text] [Related]
15. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
[TBL] [Abstract][Full Text] [Related]
16. Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
Sagatova AA; Keniya MV; Wilson RK; Monk BC; Tyndall JD
Antimicrob Agents Chemother; 2015 Aug; 59(8):4982-9. PubMed ID: 26055382
[TBL] [Abstract][Full Text] [Related]
17. Binding of a physiological substrate causes large-scale conformational reorganization in cytochrome P450 51.
Hargrove TY; Wawrzak Z; Fisher PM; Child SA; Nes WD; Guengerich FP; Waterman MR; Lepesheva GI
J Biol Chem; 2018 Dec; 293(50):19344-19353. PubMed ID: 30327430
[TBL] [Abstract][Full Text] [Related]
18. Clinical Candidate VT-1161's Antiparasitic Effect In Vitro, Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex with the Target Enzyme CYP51 from Trypanosoma cruzi.
Hoekstra WJ; Hargrove TY; Wawrzak Z; da Gama Jaen Batista D; da Silva CF; Nefertiti AS; Rachakonda G; Schotzinger RJ; Villalta F; Soeiro Mde N; Lepesheva GI
Antimicrob Agents Chemother; 2016 Feb; 60(2):1058-66. PubMed ID: 26643331
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for rational design of inhibitors targeting Trypanosoma cruzi sterol 14α-demethylase: two regions of the enzyme molecule potentiate its inhibition.
Friggeri L; Hargrove TY; Rachakonda G; Williams AD; Wawrzak Z; Di Santo R; De Vita D; Waterman MR; Tortorella S; Villalta F; Lepesheva GI
J Med Chem; 2014 Aug; 57(15):6704-17. PubMed ID: 25033013
[TBL] [Abstract][Full Text] [Related]
20. Molecular diversity of sterol 14alpha-demethylase substrates in plants, fungi and humans.
Lamb DC; Kelly DE; Kelly SL
FEBS Lett; 1998 Mar; 425(2):263-5. PubMed ID: 9559662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
